Literature DB >> 20616329

Biodistribution of neural stem cells after intravascular therapy for hypoxic-ischemia.

Arjun V Pendharkar1, Josh Y Chua, Robert H Andres, Nancy Wang, Xavier Gaeta, Hui Wang, Abhijit De, Raymond Choi, Shawn Chen, Brian K Rutt, Sanjiv S Gambhir, Raphael Guzman.   

Abstract

BACKGROUND AND
PURPOSE: Intravascular transplantation of neural stem cells represents a minimally invasive therapeutic approach for the treatment of central nervous system diseases. The cellular biodistribution after intravascular injection needs to be analyzed to determine the ideal delivery modality. We studied the biodistribution and efficiency of targeted central nervous system delivery comparing intravenous and intra-arterial (IA) administration of neural stem cells after brain ischemia.
METHODS: Mouse neural stem cells were transduced with a firefly luciferase reporter gene for bioluminescence imaging (BLI). Hypoxic-ischemia was induced in adult mice and reporter neural stem cells were transplanted IA or intravenous at 24 hours after brain ischemia. In vivo BLI was used to track transplanted cells up to 2 weeks after transplantation and ex vivo BLI was used to determine single organ biodistribution.
RESULTS: Immediately after transplantation, BLI signal from the brain was 12 times higher in IA versus intravenous injected animals (P<0.0001). After IA injection, 69% of the total luciferase activity arose from the brain early after transplantation and 93% at 1 week. After intravenous injection, 94% of the BLI signal was detected in the lungs (P=0.004) followed by an overall 94% signal loss at 1 week, indicating lack of cell survival outside the brain. Ex vivo single organ analysis showed a significantly higher BLI signal in the brain than in the lungs, liver, and kidneys at 1 week (P<0.0001) and 2 weeks in IA (P=0.007).
CONCLUSIONS: IA transplantation results in superior delivery and sustained presence of neural stem cells in the ischemic brain in comparison to intravenous infusion.

Entities:  

Mesh:

Year:  2010        PMID: 20616329      PMCID: PMC4831577          DOI: 10.1161/STROKEAHA.109.575993

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  34 in total

1.  Intravenous infusion of immortalized human mesenchymal stem cells protects against injury in a cerebral ischemia model in adult rat.

Authors:  T Honma; O Honmou; S Iihoshi; K Harada; K Houkin; H Hamada; J D Kocsis
Journal:  Exp Neurol       Date:  2005-06-20       Impact factor: 5.330

2.  Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect.

Authors:  Uwe M Fischer; Matthew T Harting; Fernando Jimenez; Werner O Monzon-Posadas; Hasen Xue; Sean I Savitz; Glen A Laine; Charles S Cox
Journal:  Stem Cells Dev       Date:  2009-06       Impact factor: 3.272

3.  Intracarotid transplantation of bone marrow stromal cells increases axon-myelin remodeling after stroke.

Authors:  L H Shen; Y Li; J Chen; J Zhang; P Vanguri; J Borneman; M Chopp
Journal:  Neuroscience       Date:  2005-11-17       Impact factor: 3.590

4.  Comparison of two neonatal ischemic injury models using magnetic resonance imaging.

Authors:  Stephen Ashwal; Beatriz Tone; Hui Rou Tian; Samuel Chong; Andre Obenaus
Journal:  Pediatr Res       Date:  2007-01       Impact factor: 3.756

5.  Neurosphere-derived multipotent precursors promote neuroprotection by an immunomodulatory mechanism.

Authors:  Stefano Pluchino; Lucia Zanotti; Barbara Rossi; Elena Brambilla; Linda Ottoboni; Giuliana Salani; Marianna Martinello; Alessandro Cattalini; Alessandra Bergami; Roberto Furlan; Giancarlo Comi; Gabriela Constantin; Gianvito Martino
Journal:  Nature       Date:  2005-07-14       Impact factor: 49.962

6.  Intravenous versus intrastriatal cord blood administration in a rodent model of stroke.

Authors:  A E Willing; J Lixian; M Milliken; S Poulos; T Zigova; S Song; C Hart; J Sanchez-Ramos; P R Sanberg
Journal:  J Neurosci Res       Date:  2003-08-01       Impact factor: 4.164

7.  Assessment of the tissue distribution of transplanted human endothelial progenitor cells by radioactive labeling.

Authors:  Alexandra Aicher; Winfried Brenner; Maaz Zuhayra; Cornel Badorff; Schirin Massoudi; Birgit Assmus; Thomas Eckey; Eberhard Henze; Andreas M Zeiher; Stefanie Dimmeler
Journal:  Circulation       Date:  2003-04-14       Impact factor: 29.690

Review 8.  Challenges and possibilities of intravascular cell therapy in stroke.

Authors:  Anna Hicks; Jukka Jolkkonen
Journal:  Acta Neurobiol Exp (Wars)       Date:  2009       Impact factor: 1.579

Review 9.  Potential of adult neural stem cells in stroke therapy.

Authors:  Robert H Andres; Raymond Choi; Gary K Steinberg; Raphael Guzman
Journal:  Regen Med       Date:  2008-11       Impact factor: 3.806

10.  Intravenous mesenchymal stem cell therapy for traumatic brain injury.

Authors:  Matthew T Harting; Fernando Jimenez; Hasan Xue; Uwe M Fischer; James Baumgartner; Pramod K Dash; Charles S Cox
Journal:  J Neurosurg       Date:  2009-06       Impact factor: 5.115

View more
  68 in total

1.  Intra-arterial transplantation of low-dose stem cells provides functional recovery without adverse effects after stroke.

Authors:  Yuhtaka Fukuda; Nobutaka Horie; Katsuya Satoh; Susumu Yamaguchi; Youichi Morofuji; Takeshi Hiu; Tsuyoshi Izumo; Kentaro Hayashi; Noriyuki Nishida; Izumi Nagata
Journal:  Cell Mol Neurobiol       Date:  2014-11-15       Impact factor: 5.046

Review 2.  Intra-arterial delivery of cell therapies for stroke.

Authors:  Vivek Misra; Aditya Lal; Ramy El Khoury; Peng R Chen; Sean I Savitz
Journal:  Stem Cells Dev       Date:  2012-02-15       Impact factor: 3.272

3.  The CCR2/CCL2 interaction mediates the transendothelial recruitment of intravascularly delivered neural stem cells to the ischemic brain.

Authors:  Robert H Andres; Raymond Choi; Arjun V Pendharkar; Xavier Gaeta; Nancy Wang; Jaya K Nathan; Joshua Y Chua; Star W Lee; Theo D Palmer; Gary K Steinberg; Raphael Guzman
Journal:  Stroke       Date:  2011-08-11       Impact factor: 7.914

Review 4.  Stem cells for brain repair in neonatal hypoxia-ischemia.

Authors:  L Chicha; T Smith; R Guzman
Journal:  Childs Nerv Syst       Date:  2013-11-01       Impact factor: 1.475

Review 5.  Current challenges for the advancement of neural stem cell biology and transplantation research.

Authors:  Kristien Reekmans; Jelle Praet; Jasmijn Daans; Veerle Reumers; Patrick Pauwels; Annemie Van der Linden; Zwi N Berneman; Peter Ponsaerts
Journal:  Stem Cell Rev Rep       Date:  2012-03       Impact factor: 5.739

Review 6.  A possible new focus for stroke treatment - migrating stem cells.

Authors:  Robert Sullivan; Kelsey Duncan; Travis Dailey; Yuji Kaneko; Naoki Tajiri; Cesario V Borlongan
Journal:  Expert Opin Biol Ther       Date:  2015-05-05       Impact factor: 4.388

Review 7.  Cell Therapy for Ischemic Stroke: How to Turn a Promising Preclinical Research into a Successful Clinical Story.

Authors:  Gabrielle Mangin; Nathalie Kubis
Journal:  Stem Cell Rev Rep       Date:  2019-04       Impact factor: 5.739

Review 8.  Cell based therapies for ischemic stroke: from basic science to bedside.

Authors:  Xinfeng Liu; Ruidong Ye; Tao Yan; Shan Ping Yu; Ling Wei; Gelin Xu; Xinying Fan; Yongjun Jiang; R Anne Stetler; George Liu; Jieli Chen
Journal:  Prog Neurobiol       Date:  2013-12-12       Impact factor: 11.685

9.  Intravascular stem cell transplantation for stroke.

Authors:  Angela M Auriat; Sahar Rosenblum; Tenille N Smith; Raphael Guzman
Journal:  Transl Stroke Res       Date:  2011-08-04       Impact factor: 6.829

10.  Neuroprotective effects of systemic cerebral endothelial cell transplantation in a rat model of cerebral ischemia.

Authors:  Jong-Hyun Moon; Joo-Young Na; Min-Cheol Lee; Kang-Ho Choi; Jeong-Kil Lee; Jung-Joon Min; Kyung-Tae Kim; Jong-Tae Park; Man-Seok Park; Hyung-Seok Kim
Journal:  Am J Transl Res       Date:  2016-05-15       Impact factor: 4.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.